Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00415415 · ClinicalTrials.gov registry record
Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 5,302
- Enrollment target
NCT00415415: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00415415 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00415415 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 5,302 participants
- Enrollment target
Study Summary
Coronary heart disease (CHD) is the leading cause of deaths that are related to cardiovascular disease in the United States, and Mississippi's CHD mortality rate is the highest in the nation. This study will examine data from the Jackson Heart Study to determine the effect of socioeconomic status and psychosocial factors on CHD risk in African Americans in Mississippi.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,302 participants |
| Start Date | 2000-09 |
| Est. Completion | 2004-03 |
What the finished NCT00415415 record still lists
NCT00415415 is an observational study that tracks outcomes without assigning an intervention. Its 5,302 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00415415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00415415 about?
NCT00415415 is a clinical study titled "Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study". Coronary heart disease (CHD) is the leading cause of deaths that are related to cardiovascular disease in the United States, and Mississippi's CHD mortality rate is the highest in the nation. This study will examine data from the Jackson Heart Study to determine the effect of socioeconomic status an...
What is the current status of trial NCT00415415?
This trial is currently completed. The enrollment target is 5,302 participants. The study started on 2000-09. Estimated completion is 2004-03.
Who is sponsoring clinical trial NCT00415415?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia